- Home
- PASG vs GROW Comparison
PASG vs GROW Comparison
Compare PASG & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- GROW
- Stock Information
- Founded
- PASG 2017
- GROW 1968
- Country
- PASG United States
- GROW United States
- Employees
- PASG N/A
- GROW N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- PASG Health Care
- GROW Finance
- Exchange
- PASG Nasdaq
- GROW Nasdaq
- Market Cap
- PASG 27.6M
- GROW 32.2M
- IPO Year
- PASG 2020
- GROW N/A
- Fundamental
- Price
- PASG $6.78
- GROW $2.38
- Analyst Decision
- PASG Strong Buy
- GROW
- Analyst Count
- PASG 4
- GROW 0
- Target Price
- PASG $59.25
- GROW N/A
- AVG Volume (30 Days)
- PASG 33.7K
- GROW 33.4K
- Earning Date
- PASG 11-10-2025
- GROW 11-12-2025
- Dividend Yield
- PASG N/A
- GROW 3.82%
- EPS Growth
- PASG N/A
- GROW N/A
- EPS
- PASG N/A
- GROW N/A
- Revenue
- PASG N/A
- GROW $8,452,000.00
- Revenue This Year
- PASG N/A
- GROW N/A
- Revenue Next Year
- PASG N/A
- GROW N/A
- P/E Ratio
- PASG N/A
- GROW N/A
- Revenue Growth
- PASG N/A
- GROW N/A
- 52 Week Low
- PASG $5.12
- GROW $2.02
- 52 Week High
- PASG $26.60
- GROW $2.78
- Technical
- Relative Strength Index (RSI)
- PASG 40.47
- GROW 31.87
- Support Level
- PASG $6.16
- GROW $2.46
- Resistance Level
- PASG $7.91
- GROW $2.56
- Average True Range (ATR)
- PASG 0.57
- GROW 0.08
- MACD
- PASG -0.16
- GROW -0.03
- Stochastic Oscillator
- PASG 19.00
- GROW 0.00
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.